Company / PP&E per Share
AVADEL PHARMACEUTICALS PLC PP&E per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2024
5-year range
$0.00 / $0.01
FY2020-FY2024
Trend
-34.7%
vs FY2023
Sector context
#170 of 191
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's pp&e per share of $0.00 is lower than 89% of companies in the Health Care sector (FY2024). PP&E per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2024 to $0.08 in FY2016.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -20.0%.
Declined from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -0.7%
- 5-Year CAGR
- -20.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, pp&e per share decreased 34.7% year-over-year.
- Ranks #170 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -34.7% |
| FY2023 | $0.01 | -47.7% |
| FY2022 | $0.01 | +186.7% |
| FY2021 | $0.00 | -25.5% |
| FY2020 | $0.01 | -55.1% |
| FY2019 | $0.01 | -71.6% |
| FY2018 | $0.05 | -28.7% |
| FY2017 | $0.07 | -10.7% |
| FY2016 | $0.08 | +34.2% |
| FY2015 | $0.06 | +22.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026